Received: 14 August 2021
Accepted: 20 April 2022
First Online: 6 May 2022
: Prior to participation, all subjects signed an informed consent form that was approved by the Helsinki Committee of Barzilai University Medical Center in Ashkelon, Israel. The study protocol was approved by the Helsinki Committee of Barzilai University Medical Center in Ashkelon, Israel (ClinicalTrials.gov registration number clinical registry number NCT01439451).
: Not applicable.
: IM and AS developed and built the BaMPer perturbation system that was used in this project. All remaining authors have nothing to declare.